Prednisone use linked to increased risk of mortality in RA

May 27, 2016

(HealthDay)—For patients with rheumatoid arthritis (RA), prednisone use is associated with an increased risk of mortality, according to a study published in the May issue of Arthritis Care & Research.

Mary Chester Wasko, M.D., from the Allegheny Health Network in Pittsburgh, Pa., and colleagues conducted a prospective study involving 5,626 RA patients followed for up to 25 years. The authors examined the risk of death associated with prednisone use alone and combined treatment of prednisone with methotrexate or sulfasalazine.

The researchers found that during a median follow-up of 4.97 years, 11.8 percent of patients died. Prednisone use was associated with increased risk of death in a multivariate, propensity-adjusted model (hazard ratio, 2.83; 95 percent confidence interval, 1.03 to 7.76). There was a significant interaction between prednisone use and methotrexate use (P = 0.03), with the risk of death attenuated for patients treated with and methotrexate (hazard ratio, 0.99; 95 percent confidence interval, 0.18 to 5.36). The protective association of methotrexate with mortality was weakened with combination treatment. Similar results were seen for sulfasalazine.

"Prednisone use was associated with a significantly increased risk of mortality in patients with RA," the authors write. "This association was mitigated by concomitant disease-modifying antirheumatic drug use, but combined treatment also negated the previously reported beneficial association of methotrexate with survival in RA."

Explore further: Methotrexate use linked to reduced mortality in RA

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Methotrexate use linked to reduced mortality in RA

October 14, 2012
(HealthDay)—Use of methotrexate for one year or more is associated with a reduction in the risk of mortality for patients with rheumatoid arthritis (RA), according to a study published online Oct. 8 in Arthritis & Rheumatism.

Some RA treatments up second nonmelanoma skin cancer risk

October 29, 2015
(HealthDay)—For patients with rheumatoid arthritis (RA) and inflammatory bowel disease (IBD) with prior nonmelanoma skin cancer (NMSC), the risk of second NMSC varies with different treatments, according to a study published ...

AAD: Herpes zoster incidence up with combo tx for psoriasis

March 23, 2015
(HealthDay)—For patients with psoriasis, combination treatment with biologic medications and methotrexate is associated with increased incidence of herpes zoster (HZ), according to a study published online March 22 in JAMA ...

Dexamethasone for asthma in the ER: Better compliance, nearly equal effectiveness

April 27, 2016
Adults with asthma who were treated with one-dose dexamethasone in the emergency department had only slightly higher relapse than patients who were treated with a 5-day course of prednisone. "Enhanced compliance and convenience ...

Two years of tamoxifen offers long-term survival benefit

May 12, 2016
(HealthDay)—For premenopausal women with breast cancer, two years of tamoxifen is associated with long-term survival benefit, according to a study published online May 9 in the Journal of Clinical Oncology.

Atomoxetine use doesn't up suicide risk in children

April 27, 2016
(HealthDay)—Treatment with the selective noradrenalin-reuptake-inhibitor atomoxetine is not associated with increased suicide risk compared with stimulant use in children and adolescents, according to a study published ...

Recommended for you

Global burden of low back pain—a consequence of negligence and misinformation

March 21, 2018
A series of groundbreaking papers from Australian and international researchers in The Lancet, published today (22/3) warns that low back pain is a major health burden globally - across developed and developing nations - ...

Microscopic 'shuttles' transport enzyme from cells to trigger onset of kidney disease

March 21, 2018
A new study involving the University of Sheffield has identified a key culprit in the onset of kidney disease in a major marker for kidney disease development.

Metabolite therapy proves effective in treating C. difficile in mice

March 20, 2018
A team of UCLA researchers found that a metabolite therapy was effective in mice for treating a serious infection of the colon known as Clostridium difficile infection, or C. difficile.

Sick air travelers mostly likely to infect next row: study

March 19, 2018
People who fly on airplanes while contagious can indeed get other people sick, but the risk is mainly to those seated next to them or in the adjacent row, US researchers said Monday.

Study of COPD patients has created a 'looking glass' into genome of pathogen

March 19, 2018
Decades of work on chronic obstructive pulmonary disease (COPD) at the University at Buffalo and the Veterans Affairs Western New York Healthcare System have yielded extraordinary information about the pathogen that does ...

Newly described human antibody prevents malaria in mice

March 19, 2018
Scientists have discovered a human antibody that protected mice from infection with the deadliest malaria parasite, Plasmodium falciparum. The research findings provide the basis for future testing in humans to determine ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.